Clinical Research Services Market Research Report by Services (Clinical Trials, Diagnostic Research, and Drug Development Consultancy), Indication, Deployment, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast t

The Global Clinical Research Services Market size was estimated at USD 48.01 billion in 2021 and expected to reach USD 52.42 billion in 2022, and is projected to grow at a CAGR 9.37% to reach USD 82.19 billion by 2027.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Clinical Research Services to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Services, the market was studied across Clinical Trials, Diagnostic Research, Drug Development Consultancy, Epidemiological Studies, Genetic Studies, Preclinical Studies, Prevention Research, Quality of Life Research, Screening Research, and Treatment Research.

Based on Indication, the market was studied across CNS Disorders, Cardio Vascular Disorders, Diabetes, Infectious Diseases, and Oncology.

Based on Deployment, the market was studied across In-House and Outsource.

Based on End User, the market was studied across Advance Pathologies, Contract Research Organizations, Medical Device Companies, and Pharmaceutical and Biopharmaceutical Companies.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Clinical Research Services market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Clinical Research Services Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Clinical Research Services Market, including Acculab Lifesciences, America Holdings, Ardent CRO, Axcent Advanced Analytics (A3), Azelix, BIO Agile Therapeutics, Charles River Laboratories International Inc., Covance Inc., CROISSANCE CLINICAL RESEARCH, CTSERV, Dove Quality Solutions, Firma Clinical Research, Fisher Clinical Services, Inc., ICON plc, IQVIA, LabCorp, Medpace Holdings, Parexel International Corporation, PEPGRA, Pharmaceutical Product Development, LLC, PRA Health Sciences, PSI CRO AG, SGS SA, Syneos Health, and Wuxi AppTec Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Clinical Research Services Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Clinical Research Services Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Clinical Research Services Market?
4. What is the competitive strategic window for opportunities in the Global Clinical Research Services Market?
5. What are the technology trends and regulatory frameworks in the Global Clinical Research Services Market?
6. What is the market share of the leading vendors in the Global Clinical Research Services Market?
7. What modes and strategic moves are considered suitable for entering the Global Clinical Research Services Market?

Please Note: PDF & Excel + Online Access - 1 Year


Companies Mentioned

Acculab Lifesciences
America Holdings
Ardent CRO
Axcent Advanced Analytics (A3)
Azelix
BIO Agile Therapeutics
Charles River Laboratories International Inc.
Covance Inc.
CROISSANCE CLINICAL RESEARCH
CTSERV
Dove Quality Solutions
Firma Clinical Research
Fisher Clinical Services, Inc.
ICON plc
IQVIA
LabCorp
Medpace Holdings
Parexel International Corporation
PEPGRA
Pharmaceutical Product Development, LLC
PRA Health Sciences
PSI CRO AG
SGS SA
Syneos Health
Wuxi AppTec Inc.

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rapid technological advancements and growing globalization encouraging biotech and pharmaceutical companies
5.1.1.2. Demand for effective drugs and healthcare devices
5.1.1.3. Surging patient population
5.1.2. Restraints
5.1.2.1. High cost associated with product development
5.1.3. Opportunities
5.1.3.1. Increasing investment in research & development activities
5.1.3.2. Expanding strategic collaboration among companies
5.1.4. Challenges
5.1.4.1. Stringent drug approval process
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Clinical Research Services Market, by Services
6.1. Introduction
6.2. Clinical Trials
6.3. Diagnostic Research
6.4. Drug Development Consultancy
6.5. Epidemiological Studies
6.6. Genetic Studies
6.7. Preclinical Studies
6.8. Prevention Research
6.9. Quality of Life Research
6.10. Screening Research
6.11. Treatment Research
7. Clinical Research Services Market, by Indication
7.1. Introduction
7.2. CNS Disorders
7.3. Cardio Vascular Disorders
7.4. Diabetes
7.5. Infectious Diseases
7.6. Oncology
8. Clinical Research Services Market, by Deployment
8.1. Introduction
8.2. In-House
8.3. Outsource
9. Clinical Research Services Market, by End User
9.1. Introduction
9.2. Advance Pathologies
9.3. Contract Research Organizations
9.4. Medical Device Companies
9.5. Pharmaceutical and Biopharmaceutical Companies
10. Americas Clinical Research Services Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Clinical Research Services Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa Clinical Research Services Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Acculab Lifesciences
14.2. America Holdings
14.3. Ardent CRO
14.4. Axcent Advanced Analytics (A3)
14.5. Azelix
14.6. BIO Agile Therapeutics
14.7. Charles River Laboratories International Inc.
14.8. Covance Inc.
14.9. CROISSANCE CLINICAL RESEARCH
14.10. CTSERV
14.11. Dove Quality Solutions
14.12. Firma Clinical Research
14.13. Fisher Clinical Services, Inc.
14.14. ICON plc
14.15. IQVIA
14.16. LabCorp
14.17. Medpace Holdings
14.18. Parexel International Corporation
14.19. PEPGRA
14.20. Pharmaceutical Product Development, LLC
14.21. PRA Health Sciences
14.22. PSI CRO AG
14.23. SGS SA
14.24. Syneos Health
14.25. Wuxi AppTec Inc.
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings